FINAL PROGRAM - Society for Immunotherapy of Cancer

Plenary and Concurrent Sessions
HIGH THROUGHPUT TECHNOLOGIES FOR IMMUNE
MONITORING
Concurrent Session
Saturday, November 5
1:30 pm – 3:00 pm
Grand Ballroom Salons G-H
Many translational clinical trials of immunotherapeutics have
incorporated longitudinal monitoring of specific facets of the
immune response. However, as scientific correlates to clinical
response are still largely lacking, these techniques continue to
evolve. New platforms for high throughput analysis for immune
monitoring, including analysis of T cell receptors, antibodies,
cytokines, gene expression and protein arrays, and germline DNA
sequencing are continuing to advance the field.
PROSTATE CANCER AS A LEARNING MODEL
Plenary Session
Sunday, November 6
8:00 am – 10:15 am
Grand Ballroom Salon E
Rapid advances are being made in the understanding of the
immunology and immunotherapy of prostate cancer. A growing
body of knowledge regarding the interactions between prostate
cancer cells and the host immune system is emerging, and the first
approval of a therapeutic cancer vaccine has been in this disease.
Prostate cancer therefore serves a valuable learning model for
considering clinical trial endpoints, selection of patient populations,
and clinical applications of cancer immunotherapies, as well as for
understanding the tumor-host interaction.
VISIT SITC’S ONLINE LEARNING LIBRARY!
View webinars and slides from the SITC Annual Meeting & Associated Programs.
Log on and have the most innovative science and education in our field at your
fingertips! Available 24 hours/day.
www.sitcancer.org
16
FINAL PROGRAM • SITC 26 TH ANNUAL MEETING
November 4-6, 2011 • North Bethesda, MD • www.sitcancer.org